Impact Partnership Wealth’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$974K Sell
8,824
-251
-3% -$24.2K 0.09% 155
2026
Q2
$710K Buy
9,075
+1,861
+26% +$127K 0.07% 195
2026
Q1
$466K Buy
7,214
+552
+8% +$38.9K 0.06% 210
2025
Q4
$448K Buy
+6,662
New +$448K 0.06% 212

Other funds holding HALO

Impact Partnership Wealth's HALO Position: Q3 2026 in Review

Impact Partnership Wealth reduced its Halozyme (HALO) stake by 2.8% in Q3 2026, selling an estimated $24.2K and leaving 8,824 shares worth $974K. The position accounts for 0.09% of the portfolio, ranked #155.

Impact Partnership Wealth first reported a position in HALO in Q4 2025 and has held it in 4 quarters since. 536 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Impact Partnership Wealth held 8,824 shares of Halozyme worth $974K as of Q3 2026.
  • Impact Partnership Wealth sold 251 Halozyme shares in Q3 2026, an estimated $24.2K.
  • Halozyme made up 0.09% of Impact Partnership Wealth's portfolio in Q3 2026, its #155 holding.
  • Impact Partnership Wealth first reported a position in Halozyme in Q4 2025 and has held it in 4 quarters since.
  • 536 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Impact Partnership Wealth's 13F filing for Q3 2026, filed 9 Nov 2026.